EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $235,982 | -64.2% | 8,318 | -63.1% | 0.04% | -72.2% |
| Q4 2022 | $659,049 | -47.7% | 22,547 | -52.8% | 0.16% | -44.9% |
| Q3 2022 | $1,261,000 | +481.1% | 47,727 | +876.6% | 0.29% | +394.8% |
| Q2 2022 | $217,000 | -43.8% | 4,887 | -37.3% | 0.06% | -44.2% |
| Q1 2022 | $386,000 | +15.6% | 7,800 | +4.2% | 0.10% | -68.4% |
| Q4 2018 | $334,000 | -3.7% | 7,488 | +49.8% | 0.33% | +39.4% |
| Q3 2018 | $347,000 | +54.2% | 5,000 | +18.5% | 0.24% | +42.2% |
| Q4 2017 | $225,000 | – | 4,218 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |